NOVO-B.CO vs. DHR

Last updated Jun 9, 2026

NOVO-B.CO (Novo Nordisk A/S) and DHR (Danaher Corporation) are both stocks. Both are in the Healthcare sector — NOVO-B.CO in Biotechnology, DHR in Diagnostics & Research. Over the past 10 years, NOVO-B.CO returned 15.87%/yr vs 10.97%/yr for DHR. At a 0.18 correlation, their price movements are largely independent.

Performance

NOVO-B.CO vs. DHR - Performance Comparison

The chart below illustrates the hypothetical performance of a DKK 10,000 investment in Novo Nordisk A/S (NOVO-B.CO) and Danaher Corporation (DHR). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

NOVO-B.CO is traded in DKK, while DHR is traded in USD. To make them comparable, the DHR values have been converted to DKK using the latest available exchange rates.

Returns By Period

In the year-to-date period, NOVO-B.CO achieves a -14.51% return, which is significantly higher than DHR's -18.18% return. Over the past 10 years, NOVO-B.CO has outperformed DHR with an annualized return of 15.87%, while DHR has yielded a comparatively lower 10.97% annualized return.

NOVO-B.CO

• 1D: -1.18%
• 1M: -7.41%
• YTD: -14.51%
• 6M: -7.00%
• 1Y: -42.63%
• 3Y*: 2.27%
• 5Y*: 19.11%
• 10Y*: 15.87%

DHR

• 1D: -0.58%
• 1M: 9.51%
• YTD: -18.18%
• 6M: -17.22%
• 1Y: -6.73%
• 3Y*: -5.83%
• 5Y*: -1.36%
• 10Y*: 10.97%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NOVO-B.CO vs. DHR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NOVO-B.CO Novo Nordisk A/S	-14.51%	-46.40%	-9.59%	205.34%	31.49%	79.08%	15.29%	36.17%	-6.15%	39.57%
DHR Danaher Corporation	-18.18%	-11.40%	6.28%	-3.94%	-13.97%	59.46%	32.83%	53.05%	17.34%	5.37%

Correlation

The correlation between NOVO-B.CO and DHR is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.13
Correlation (5Y) Calculated over the trailing 5-year period	0.16
Correlation (10Y) Calculated over the trailing 10-year period	0.18
Correlation (All Time) Calculated using the full available price history since Sep 4, 2007	0.18

Return for Risk

NOVO-B.CO vs. DHR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NOVO-B.CO

NOVO-B.CO Risk / Return Rank: 13
NOVO-B.CO Sharpe Ratio Rank: 10
NOVO-B.CO Sortino Ratio Rank: 13
NOVO-B.CO Omega Ratio Rank: 12
NOVO-B.CO Calmar Ratio Rank: 12
NOVO-B.CO Martin Ratio Rank: 17

DHR

DHR Risk / Return Rank: 32
DHR Sharpe Ratio Rank: 33
DHR Sortino Ratio Rank: 29
DHR Omega Ratio Rank: 29
DHR Calmar Ratio Rank: 37
DHR Martin Ratio Rank: 34

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NOVO-B.CO vs. DHR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOVO-B.CO) and Danaher Corporation (DHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NOVO-B.CO	DHR	Difference
Sharpe ratio: Return per unit of total volatility	-0.79	-0.25	-0.54
Sortino ratio: Return per unit of downside risk	-0.93	-0.18	-0.75
Omega ratio: Gain probability vs. loss probability	0.87	0.98	-0.11
Calmar ratio: Return relative to maximum drawdown	-0.79	-0.21	-0.58
Martin ratio: Return relative to average drawdown	-1.16	-0.50	-0.66
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NOVO-B.CO vs. DHR - Sharpe Ratio Comparison

The current NOVO-B.CO Sharpe Ratio is -0.79, which is lower than the DHR Sharpe Ratio of -0.25. The chart below compares the historical Sharpe Ratios of NOVO-B.CO and DHR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NOVO-B.CO	DHR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.79	-0.25	-0.54
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.33	-0.05	+0.38
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.36	0.43	-0.08
Sharpe Ratio (All Time) Calculated using the full available price history	0.78	0.49	+0.29

Drawdowns

NOVO-B.CO vs. DHR - Drawdown Comparison

The maximum NOVO-B.CO drawdown since its inception was -76.75%, which is greater than DHR's maximum drawdown of -45.92%. Use the drawdown chart below to compare losses from any high point for NOVO-B.CO and DHR.

Drawdown Indicators

	NOVO-B.CO	DHR	Difference
Max Drawdown Largest peak-to-trough decline	-76.75%	-45.92%	-30.83%
Max Drawdown (1Y) Largest decline over 1 year	-54.94%	-32.58%	-22.36%
Max Drawdown (3Y) Largest decline over 3 years	-76.75%	-45.81%	-30.94%
Max Drawdown (5Y) Largest decline over 5 years	-76.75%	-45.92%	-30.83%
Max Drawdown (10Y) Largest decline over 10 years	-76.75%	-45.92%	-30.83%
Current Drawdown Current decline from peak	-72.07%	-38.25%	-33.82%
Average Drawdown Average peak-to-trough decline	-11.25%	-10.48%	-0.77%
Ulcer Index Depth and duration of drawdowns from previous peaks	36.82%	13.52%	+23.30%

Volatility

NOVO-B.CO vs. DHR - Volatility Comparison

Novo Nordisk A/S (NOVO-B.CO) has a higher volatility of 10.59% compared to Danaher Corporation (DHR) at 9.05%. This indicates that NOVO-B.CO's price experiences larger fluctuations and is considered to be riskier than DHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NOVO-B.CO	DHR	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.59%	9.05%	+1.54%
Volatility (6M) Calculated over the trailing 6-month period	39.29%	18.91%	+20.38%
Volatility (1Y) Calculated over the trailing 1-year period	54.59%	27.26%	+27.33%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	58.54%	27.40%	+31.14%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	45.06%	25.53%	+19.53%

Dividends

NOVO-B.CO vs. DHR - Dividend Comparison

NOVO-B.CO's dividend yield for the trailing twelve months is around 4.35%, more than DHR's 0.74% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
DHR Danaher Corporation	0.74%	0.56%	0.47%	12.64%	0.38%	0.26%	0.32%	0.44%	0.62%	0.60%	32.55%	0.58%
NOVO-B.CO Novo Nordisk A/S	4.35%	3.58%	1.59%	1.01%	2.38%	2.54%	4.03%	4.22%	5.27%	4.54%	7.38%	2.50%

Financials

Frequently Asked Questions

Can I hold both NOVO-B.CO and DHR in my portfolio?

NOVO-B.CO and DHR have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.